Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae, Northeast Florida

Southern Medical Journal

Volumn 102, Issue 7, 2009, Pages 680-687

  Halstead, Diane C ^a   Sellen, Timothy J ^b   Adams Haduch, Jennifer M ^b   Dossenback, Deborah A ^b   Abid, Joan ^b   Doi, Yohei ^b   Paterson, David L ^b  

^a Infectious Disease Laboratories   (United States)

^b NONE

Author keywords

Carbapenemase producing; Enterobacteriaceae; Multidrug resistant

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEPHAMYCIN; CLAVULANIC ACID; DORIPENEM; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TIGECYCLINE; TOBRAMYCIN; BACTERIAL PROTEIN; BETA LACTAMASE; BETA LACTAMASE KPC 3, KLEBSIELLA PNEUMONIAE; BETA-LACTAMASE KPC-3, KLEBSIELLA PNEUMONIAE; CARBAPENEM DERIVATIVE; CARBAPENEMASE 2, KLEBSIELLA PNEUMONIAE; CARBAPENEMASE-2, KLEBSIELLA PNEUMONIAE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; DEBRIDEMENT; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; EPIDEMIC; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; OSTEOMYELITIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SEPSIS; TREATMENT OUTCOME; UNITED STATES; WOUND INFECTION; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENETICS; GENOTYPE; KLEBSIELLA INFECTION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLORIDA; GENOTYPE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; YOUNG ADULT;

EID: 67650296958     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181a93f9e     Document Type: Article

References (17)

1. Siegel JD, Rinehart E, Jackson M, et al. The Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings. 2006. Available at: http:// www.cdc.gov/ncidod/ dhqp/pdf/ar/mdroGuideline2006.pdf Accessed 18 December 2008.
2. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151-1161. (Pubitemid 32230996)
3. Smith Moland E, Hanson ND, Herrera VL, et al. Plasmid-mediated, carbapenem-hydrolyzing beta-lactamase, KPC-2 in Klebsiella pneumoniae isolates. J Antimicrob Chemother 2003;51:711-714.
4. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2008;52:809.
5. Woodford N, Tierno PM Jr, Young K, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A betalactamase, KPC-3, in a New York medical center. Antimicrob Agents Chemother 2004;48:4793-4799. (Pubitemid 39577686)
6. Bratu S, Mooty M, Nichani S, et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 2005;49:3018-3020. (Pubitemid 40917631)
7. Lee K, Chong Y, Shin HB, et al. Modified Hodge and EDTA-disk synergy tests to screen metallo-B-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001;7:88-91. (Pubitemid 34960278)
8. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
9. Anderson KF, Lonsway DR, Rasheed JK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007;45:2723-2725.
10. Deshpande LM, Rhomberg PR, Sader HS, et al. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States medical centers: report from the MYSTIC program (1999-2005). Diagn Microbiol Infect Dis 2006;56:367-372.
11. Moland ES, Soo-Young K, Hong SG, et al. Newer B-Lactamases: clinical and laboratory implications, Part II. Clin Microbial News 2008;30:79-85.
12. Navon-Venezia S, Chmelnitsky I, Leavitt A, et al. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2006;50:3098-3101. (Pubitemid 44396417)
13. Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:1430-1435. (Pubitemid 40973427)
14. Bratu S, Tolaney P, Karumudi U, et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 2005; 56:128-132. (Pubitemid 41418346)
15. Pope J, Adams J, Doi Y. KPC type beta-lactamase, rural Pennsylvania. Emerg Infect Dis 2006;12:1613-1614. (Pubitemid 44570918)
16. Clinical and Laboratory Standards Institute. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. Wayne, PA, Clinical and Laboratory Standards Institute, M100-S19, January, 2009.
17. Tenover FC, Kalsi RK, Williams PP, et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 2006;12:1209-1213.